Winnergy Medical Public : Report on the Utilization of Proceeds from offering the newly ordinary issued shares by way of the Initial Public Offering (IPO) as of 30 June 2022
July 26, 2022 at 08:09 am EDT
Share
Ref. No. CPO-08 / 2022
26 July 2022
Subject
Report on the Utilization of Proceeds from offering the newly ordinary issued shares by way of the Initial
Public Offering (IPO) as of 30 June 2022
To
The President
The Stock Exchange of Thailand
With reference to Winnergy Medical Public Company Limited (the "Company") has offered the newly issued shares by way of initial public offering (IPO) in the subscription period from 30 April 2021 and from 5 to 6 May 2022, in the number of 120 million shares with a par value of THB 0.50 at an offering price of THB 3.10, with a total offering value of THB 372 million. The Company has received the net proceeds (after deducting underwriting fee and other related fee) of THB 349.48 million.
In this regard, the Company would like to report the utilization of proceeds from the Initial Public Offering (IPO) as of 30 June 2022, as follows:
Unit: THB milion
Proceeds Utilization Purpose
Approximately
Actual Spending Amount
Remaining Amount
Amount
until 30 June 2022
as of 30 June 2022
1.
Investing in the construction
18.00
10.26
7.74
of a laboratory for HPV
detection through a self-
collect vaginal cell collection
kit.
2.
Investing in the construction
79.00
21.19
57.81
of a laboratory for the
preparation of cell products
for cell therapy.
3.
Investing in the construction
25.00
12.03
12.97
of a laboratory for COVID-19
detection
_________WINNERGY…………Winning Together Through Synergy___________________________________________________________
Proceeds Utilization Purpose
Approximately
Actual Spending Amount
Remaining Amount
Amount
until 30 June 2022
as of 30 June 2022
4.
Loan repayment
200.00
200.00
-
5.
Use as working capital
27.48
27.48
-
Total
349.48
270.96
78.52
Please be informed accordingly.
Yours Sincerely,
(Mr. Nanthiya Darakananda)
Chief Executive Office
Winnergy Medical Public Company Limited
Company Secretary
Tel: 02-725-0888
_________WINNERGY…………Winning Together Through Synergy___________________________________________________________
Attachments
Original Link
Original Document
Permalink
Disclaimer
Winnergy Medical pcl published this content on 26 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2022 12:08:07 UTC.
Winnergy Medical Public Company Limited is a Thailand-based company, which is engaged in the distribution of medical and diagnostics equipment. The Company imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The Company operates through two segments: Medical products and Other products. The Company's businesses include Trading business and Laboratory services. Its Trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The Company imports cytology and molecular microbiology products from Hologic Co., Ltd. from the United States. The Company imports products related to blood donation from Haemonetics Company of the United States. It distributes blood diagnostics products from Grifols, Spain. The Company also distributes clinical products, including reagents, such as Clinical cell separation, In vitro diagnostic (IVD) and Analyte specific reagents (ASR).
Winnergy Medical Public : Report on the Utilization of Proceeds from offering the newly ordinary issued shares by way of the Initial Public Offering (IPO) as of 30 June 2022